Equities

SWS Hemodialysis Care Co Ltd

688410:SHH

SWS Hemodialysis Care Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)12.33
  • Today's Change-0.55 / -4.27%
  • Shares traded3.88m
  • 1 Year change-41.08%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SWS Hemodialysis Care Co Ltd is a China-based company specializing in the research, development, production and sales of blood purification equipment and consumables. The Company's main products and services include blood purification equipment, blood purification consumables, and chain hemodialysis center medical services. The blood purification equipment includes continuous blood purification equipment, hemodialysis machines, hemoperfusion machines and others. The blood purification consumables include self-branded and distributed brands of dialysate filters, hemodialyzers and others. The chain hemodialysis center medical services provide hemodialysis medical services for patients with kidney diseases.

  • Revenue in CNY (TTM)532.45m
  • Net income in CNY74.82m
  • Incorporated2001
  • Employees881.00
  • Location
    SWS Hemodialysis Care Co LtdNo. 1 Ciji Road, LiangJiang New DistrictCHONGQING ChinaCHN
  • Phone+86 2 367460800
  • Fax+86 2 368690058
  • Websitehttp://www.swskj.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Chimin Health Management Co Ltd899.55m-82.14m3.89bn1.95k--2.53--4.33-0.1882-0.18821.742.930.35623.934.91462,018.90-3.051.54-3.902.4140.5644.32-8.584.051.24-3.660.245429.556.845.09-289.97---10.57--
Well Lead Medical Co Ltd1.47bn215.29m3.90bn2.62k17.972.12--2.650.74020.74025.066.270.57624.687.77561,039.908.818.2510.5610.1744.3743.4515.2913.041.49239.620.231851.111.7913.2215.5624.1035.3945.41
SWS Hemodialysis Care Co Ltd532.45m74.82m3.96bn881.0052.912.34--7.440.2330.2331.665.270.27591.864.66604,373.603.72--4.02--46.37--13.47--10.93--0.016--80.65--228.34------
Goodwill E-Health Info Co Ltd633.21m-16.79m4.13bn2.05k--2.31--6.52-0.1239-0.12394.5912.990.24720.54430.7415308,883.90-1.281.28-1.781.9549.2150.60-5.183.481.75-2.750.14730.00-3.0422.09-37.53--66.10--
Sino Medical Sciences Technology Inc417.13m-4.63m4.24bn652.00--4.95--10.17-0.0112-0.01121.012.070.34981.4533.50639,765.50-0.3445-4.21-0.411-4.7160.2270.96-0.985-15.761.61--0.1327--77.99-2.0475.59---7.30--
Getein Biotech Inc1.25bn252.99m4.37bn2.14k17.261.68--3.500.49880.49882.465.120.32411.622.91584,007.906.7313.259.8618.4567.6465.5720.7628.131.69--0.20529.88-24.8514.81-43.922.3118.446.00
Qingdao NovelBeam Technology Co Ltd413.02m124.91m4.40bn797.0035.173.43--10.661.041.043.4410.630.29620.86634.68518,221.708.8114.679.3716.6363.8562.3229.7334.159.12--0.026233.55-1.3118.58-20.1921.7110.45--
Data as of Nov 15 2024. Currency figures normalised to SWS Hemodialysis Care Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.92%Per cent of shares held by top holders
HolderShares% Held
E Fund Management Co., Ltd.as of 30 Jun 202412.59m5.37%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20242.38m1.02%
SWS MU Fund Management Co., Ltd.as of 30 Jun 20241.66m0.71%
First Seafront Fund Management Co., Ltd.as of 30 Jun 2024908.67k0.39%
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024819.48k0.35%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024753.11k0.32%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2024646.29k0.28%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2024436.57k0.19%
Bosera Asset Management Co., Ltd.as of 30 Jun 2024390.88k0.17%
HuaAn Fund Management Co., Ltd.as of 30 Jun 2024319.69k0.14%
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.